- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)
This study is testing a new medicine, Batoclimab, for people with an eye condition called Thyroid Eye Disease (TED). We want to see if this medicine can help reduce bulging eyes and improve other eye symptoms compared to a dummy medicine.
For: Thyroid Eye DiseaseSlovakia · Spain · Hungary - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants with Generalized Myasthenia Gravis (gMG)
This study is looking into a new treatment called Batoclimab for adults with a muscle weakness condition called generalized Myasthenia Gravis (gMG). It wants to see if the treatment helps improve daily activities and if it's safe to use.
For: Generalized Myasthenia Gravis (gMG)Romania · Germany · Italy - Ongoing, recruitingTherapeutic confirmatory (Phase III)
An Open-label Extension Study for Participants who Completed Study IMVT-1401-3201 or Study IMVT-1401-3202 to Assess the Efficacy and Safety of Batoclimab for the Treatment of Thyroid Eye Disease (TED)
This study looks at a new medicine called batoclimab for Thyroid Eye Disease (TED). It’s for people who have already taken part in similar batoclimab studies. We want to see how long their eyes stay improved after stopping the medicine and if it helps those who didn't respond before.
For: Thyroid Eye Disease (TED)Slovakia · Hungary · Belgium - Ongoing, recruitingTherapeutic confirmatory (Phase III)
IMVT-1401-3201: A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)
This study is testing a new medicine, batoclimab, for active Thyroid Eye Disease (TED). We want to see if it can help reduce bulging eyes (proptosis) and improve other symptoms, compared to a dummy medicine, in adults with TED.
For: Thyroid Eye Disease (TED)Italy · Poland · Germany - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2b, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study of Batoclimab Treatment in Adult Participants with Active Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
This study is testing a new medicine, Batoclimab, for adults with a condition called Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Researchers want to see if this medicine can stop CIDP symptoms from getting worse, compared to a dummy medicine. It's an important step to find better treatments.
For: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Sweden · Spain · Norway - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Proof-of-Concept, Open-label Study to Assess the Safety and Efficacy of Batoclimab in Participants with Graves’ Disease (GD)
This study is testing a new medicine, Batoclimab, for Graves' disease. Researchers want to see if it's safe and helps control thyroid hormone levels, aiming for them to be normal or lower, without needing more of current thyroid medication.
For: Grave's diseaseGermany - Ongoing, recruitingTherapeutic exploratory (Phase II)
An Open-Label Extension Study to Assess Long-term Safety and Tolerability of Batoclimab in Adult Participants with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
This study looks at the long-term safety of a new medicine called Batoclimab for adults with a nerve condition called CIDP. It mainly checks for any side effects and how well people tolerate the treatment over time.
For: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Belgium · Denmark · Italy